ACET — Adicet Bio, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1720580 ·
Last close
$8.05
Market Cap
$75.25M
52W High
$9.47
52W Low
$6.01
ADV30
103,023
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -21,570,000 | -20,244,000 | 169,382,000 | 36,245,000 | 29,317,000 |
| Dec 2025 | 0 | — | -31,886,000 | -30,516,000 | 192,355,000 | 38,918,000 | 33,145,000 |
| Sep 2025 | 0 | — | -27,952,000 | -26,856,000 | 140,479,000 | 29,099,000 | 31,337,000 |
| Jun 2025 | 0 | — | -32,392,000 | -31,217,000 | 162,972,000 | 34,720,000 | 29,600,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-91,339,000
Investing CF
$24,133,000
Financing CF
$75,284,000
CapEx
$-1,785,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-14.90
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-634,941,000
Inventory
—
Receivables
$405,000
ST Investments
$101,347,000
EBIT TTM
$-108,774,000
Pretax Income TTM
$-108,833,000
Interest Exp TTM
$59,000
Analysts
6
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -122,114,000 | -116,803,000 | 192,355,000 | 33,145,000 | — | -95,246,000 |
| Dec 2024 | 0 | -127,615,000 | -117,122,000 | 220,219,000 | 33,610,000 | — | -92,378,000 |
| Dec 2023 | 0 | -132,576,000 | -142,658,000 | 207,295,000 | 37,120,000 | — | -93,717,000 |
| Dec 2022 | 24,990,000 | -72,551,000 | -69,790,000 | 330,690,000 | 38,352,000 | — | -44,765,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-4.19
Max Pain — expiry 2026-07-17 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $8.11 · call volume: 77 · put volume: 3
Expected Move to 2026-07-17:
±$3.67
(45.31%) —
implied range
$4.43 –
$11.78
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | $75.71M | $0.40 | — |
| OSTX | OS Therapies Inc | $75.71M | $1.70 | — |
| ANVS | Annovis Bio, Inc. | $75.72M | $1.78 | — |
| CLNN | Clene Inc. | $74.63M | $5.84 | — |
| ATHE | ALTERITY THERAPEUTICS LTD | $76.31M | $4.21 | — |
News headlines (Yahoo Finance, 1h cache)
Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference
2026-06-04 18:04 · Yahoo
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
2026-05-28 13:40 · Yahoo
Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade
2026-05-25 13:55 · Yahoo
Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference
2026-05-14 20:00 · Yahoo
Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
2026-05-13 20:01 · Yahoo
Adicet Bio (ACET) Upgraded to Buy: Here's Why
2026-03-24 16:00 · Yahoo
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
2026-03-12 20:00 · Yahoo
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
2026-01-30 12:00 · Yahoo
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
2026-01-07 12:00 · Yahoo
Adicet Bio Announces Reverse Stock Split
2025-12-26 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.